Equillium (EQ) Other Accumulated Expenses (2017 - 2026)
Equillium (EQ) reported Other Accumulated Expenses of $418000.0 for Q1 2026, down 35.59% year-over-year from $649000.0 in Q1 2025, and up 96.24% quarter-over-quarter from $213000.0 in Q4 2025.
Equillium (EQ) Other Accumulated Expenses (2017 - 2026) Analysis & Trends
Equillium (EQ) has 10 years of Other Accumulated Expenses data on file, last reported at $418000.0 in Q1 2026.
- Other Accumulated Expenses for Q1 2026 came in at $418000.0, down 35.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $418000.0 (down 35.59% YoY), and the FY2025 annual result was $213000.0, down 29.7% from the prior year.
- Other Accumulated Expenses advanced to $418000.0 in Q1 2026 per EQ's latest filing, from $213000.0 in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $749000.0 in Q3 2022 and troughed at $129000.0 in Q2 2025.
- A 5-year average of $440647.1 and a median of $431000.0 in 2023 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2022 and 2025: Other Accumulated Expenses jumped 345.83% in 2022, then plunged 67.75% in 2025.
- A 5-year view of Other Accumulated Expenses shows it stood at $472000.0 in 2022, then fell by 8.69% to $431000.0 in 2023, then slipped by 29.7% to $303000.0 in 2024, then declined by 29.7% to $213000.0 in 2025, then soared by 96.24% to $418000.0 in 2026.
- Business Quant data shows EQ's Other Accumulated Expenses at $418000.0 in Q1 2026, $213000.0 in Q4 2025, and $253000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 418,000.00 |
| Dec 31, 2025 | 213,000.00 |
| Sep 30, 2025 | 253,000.00 |
| Jun 30, 2025 | 129,000.00 |
| Mar 31, 2025 | 649,000.00 |
| Dec 31, 2024 | 303,000.00 |
| Sep 30, 2024 | 443,000.00 |
| Jun 30, 2024 | 400,000.00 |
| Mar 31, 2024 | 483,000.00 |
| Dec 31, 2023 | 431,000.00 |
| Sep 30, 2023 | 595,000.00 |
| Jun 30, 2023 | 661,000.00 |
| Mar 31, 2023 | 732,000.00 |
| Dec 31, 2022 | 472,000.00 |
| Sep 30, 2022 | 749,000.00 |
| Jun 30, 2022 | 252,000.00 |
| Mar 31, 2022 | 308,000.00 |
| Dec 31, 2021 | 245,000.00 |
| Sep 30, 2021 | 168,000.00 |
| Jun 30, 2021 | 224,000.00 |